Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Regeneus Ltd. ( (AU:CMB) ) is now available.
Cambium Bio Limited, a company involved in biotechnology, has announced a change in its substantial holding. The company’s voting power has decreased from 20.7% to 13.5% due to a share consolidation and subsequent dilution following a share placement. This change in voting power could impact the company’s influence in decision-making and its strategic direction, affecting stakeholders’ interests.
More about Regeneus Ltd.
YTD Price Performance: -12.50%
Average Trading Volume: 23,974
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$6.4M
Learn more about CMB stock on TipRanks’ Stock Analysis page.

